Collegium Pharmaceutical, Inc. COLL Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $74.95M+70.7% | $62.87M-9.1% | $58.44M-34.0% | $36.27M-63.7% | $43.89M-53.0% | ||
| $3.55M-11.8% | $4.18M+8.5% | $4.3M+14.2% | $4.21M+15.3% | $4.03M+12.1% | ||
| $41.26M+13.2% | $41.91M+29.3% | $39.75M+25.0% | $37.26M+18.2% | $36.45M+27.6% | ||
| $331.04M+59.6% | $329.32M+53.9% | $290.92M+43.5% | $212.48M-23.2% | $207.44M-32.9% | ||
| $1.21M-35.6% | $1.74M+5.3% | $1.62M+30.1% | $1.68M+57.2% | $1.88M+121% | ||
| -$52.23M+81.3% | -$63.53M+77.9% | -$55.23M+81.7% | -$273.32M-388% | -$279.31M-215% | ||
| $626.66M+702% | $635.56M+490% | $64.58M-53.0% | $48.44M-73.6% | $78.13M-57.4% | ||
| -$106.35M— | -$110.25M— | -$129.7M— | —— | —— | ||
| $172.46M— | $155.55M— | —— | —— | —— | ||
| $329.83M+60.3% | $327.58M+54.1% | $289.3M+43.5% | $211.05M-23.4% | $205.8M-33.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Collegium Pharmaceutical, Inc. generate?
- Collegium Pharmaceutical, Inc. (COLL) generated $331.0M in operating cash flow over the trailing twelve months.
- What is Collegium Pharmaceutical, Inc.'s free cash flow?
- After $1.2M of capital expenditures, Collegium Pharmaceutical, Inc.'s free cash flow was $329.8M over the trailing twelve months, up 60.3% year over year.
- Where does Collegium Pharmaceutical, Inc.'s cash flow data come from?
- Every line is extracted from Collegium Pharmaceutical, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
